Internal Medicine, Endocrinology, Diabetes, & Metabolism · Kansas City, KS
NPI
1841313608
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3901 Rainbow Blvd, Mail Stop 2024
Kansas City, KS, 66103
Phone (913) 588-6022
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,055 services
Medicare patients, 2024
492
Average age 70
Drug cost, 2024
$376K
1,134 prescriptions
Company payments, 2025
$623
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rudruidee Karnchanasorn was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 218 times for 191 patients. In total Rudruidee Karnchanasorn billed 1,055 services in 19 codes, and Medicare paid $47K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 218 | 191 | $12.50 | $2,725 |
| 99214 Office E&M - Established | Facility | 185 | 155 | $66.04 | $12K |
| 77080 Standard X-ray | Facility | 155 | 155 | $9.15 | $1,418 |
| 99232 Hospital E&M - Subsequent | Facility | 153 | 56 | $60.31 | $9,227 |
| 99231 Hospital E&M - Subsequent | Facility | 94 | 50 | $38.00 | $3,572 |
| 99204 Office E&M - New | Facility | 60 | 60 | $86.85 | $5,211 |
| 99222 Hospital E&M - Initial | Facility | 57 | 52 | $100.23 | $5,713 |
| 99214 Office E&M - Established | Office | 29 | 25 | $91.99 | $2,668 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 24 | $12.76 | $345 |
| 99213 Office E&M - Established | Facility | 21 | 21 | $44.68 | $938 |
| 95251 Test - Miscellaneous | Facility | 15 | 11 | $24.02 | $360 |
| 10005 Other Organ Systems | Facility | 11 | 11 | $55.33 | $609 |
By year: 2022 $45K for 811 services; 2023 $41K for 751 services; 2024 $47K for 1,055 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rudruidee Karnchanasorn prescribed most often to Medicare patients was Levothyroxine Sodium, with 203 prescriptions and refills. In total Rudruidee Karnchanasorn wrote 1,134 Medicare prescriptions that cost $376K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 203 | 525 | 64 | $3,157 |
| Alendronate Sodium Generic | 58 | 161 | 22 | $646 |
| Hydrocortisone Generic | 56 | 147 | 18 | $4,069 |
| Synthroid Levothyroxine Sodium | 54 | 115 | 12 | $3,576 |
| Prednisone Generic | 52 | 98 | Under 11 | $591 |
| Methimazole Generic | 40 | 100 | 14 | $514 |
| Novolog Flexpen Insulin Aspart | 32 | 52 | 11 | $8,440 |
| Ozempic Semaglutide | 27 | 36 | 11 | $33K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 26 | 57 | Under 11 | $3,033 |
| Rosuvastatin Calcium Generic | 25 | 75 | Under 11 | $2,507 |
| Metformin Hcl Er Metformin Hcl | 23 | 66 | 12 | $125 |
| Jardiance Empagliflozin | 22 | 48 | Under 11 | $28K |
| Genotropin Somatropin | 22 | 30 | Under 11 | $98K |
| Metformin Hcl Generic | 21 | 60 | Under 11 | $248 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 20 | 46 | Under 11 | $3,837 |
Brand drugs: 482 claims; generic drugs: 582 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rudruidee Karnchanasorn $623 ($623 in general payments such as food, travel and fees) from 9 companies. The largest payer was Chiesi USA, Inc. with $325.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.